Literature DB >> 3294077

CAMP-dependent protein kinase: prototype for a family of enzymes.

S S Taylor1, J Bubis, J Toner-Webb, L D Saraswat, E A First, J A Buechler, D R Knighton, J Sowadski.   

Abstract

Protein kinases represent a diverse family of enzymes that play critical roles in regulation. The simplest and best-understood biochemically is the catalytic (C) subunit of cAMP-dependent protein kinase, which can serve as a framework for the entire family. The amino-terminal portion of the C subunit constitutes a nucleotide binding site based on affinity labeling, labeling of lysines, and a conserved triad of glycines. The region beyond this nucleotide fold also contains essential residues. Modification of Asp 184 with a hydrophobic carbodiimide leads to inactivation, and this residue may function as a general base in catalysis. Despite the diversity of the kinase family, all share a homologous catalytic core, and the residues essential for nucleotide binding or catalysis in the C subunit are invariant in every protein kinase. Affinity labeling and intersubunit cross-linking have localized a portion of the peptide binding site, and this region is variable in the kinase family. The crystal structure of the C subunit also is being solved. The C subunit is maintained in its inactive state by forming a holoenzyme complex with an inhibitory regulatory (R) subunit. This R subunit has a well-defined domain structure that includes two tandem cAMP binding domains at the carboxy-terminus, each of which is homologous to the catabolite gene activator protein in Escherichia coli. Affinity labeling with 8N3 cAMP has identified residues that are in close proximity to the cAMP binding sites and is consistent with models of the cAMP binding sites based on the coordinates of the CAP crystal structure. An expression vector was constructed for the RI subunit and several mutations have been introduced. These mutations address 1) the major site of photoaffinity labeling, 2) a conserved arginine in the cAMP binding site, and 3) the consequences of deleting the entire second cAMP binding domain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294077     DOI: 10.1096/fasebj.2.11.3294077

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  11 in total

1.  Affinity reagents that target a specific inactive form of protein kinases.

Authors:  Pratistha Ranjitkar; Amanda M Brock; Dustin J Maly
Journal:  Chem Biol       Date:  2010-02-26

2.  Mutation of a kinase allosteric node uncouples dynamics linked to phosphotransfer.

Authors:  Lalima G Ahuja; Alexandr P Kornev; Christopher L McClendon; Gianluigi Veglia; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-23       Impact factor: 11.205

Review 3.  Bivalent inhibitors of protein kinases.

Authors:  Carrie M Gower; Matthew E K Chang; Dustin J Maly
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-25       Impact factor: 8.250

4.  Ala99ser mutation in RI alpha regulatory subunit of protein kinase A causes reduced kinase activation by cAMP and arrest of hormone-dependent breast cancer cell growth.

Authors:  G R Lee; S N Kim; K Noguchi; S D Park; S H Hong; Y S Cho-Chung
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

5.  Affinity labeling of Avena phytochrome with ATP analogs.

Authors:  Y S Wong; J C Lagarias
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Secretagogue and second messenger-activated Cl- permeabilities in isolated pancreatic zymogen granules.

Authors:  C M Fuller; H H Deetjen; A Piiper; I Schulz
Journal:  Pflugers Arch       Date:  1989-10       Impact factor: 3.657

7.  Point mutation of the autophosphorylation site or in the nuclear location signal causes protein kinase A RII beta regulatory subunit to lose its ability to revert transformed fibroblasts.

Authors:  A Budillon; A Cereseto; A Kondrashin; M Nesterova; G Merlo; T Clair; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  A 20 kDa erythrocyte membrane phosphoprotein.

Authors:  S Lee; E B Cunningham; N I Swislocki
Journal:  Mol Cell Biochem       Date:  1991-07-24       Impact factor: 3.396

Review 9.  Biochemical mechanisms of resistance to small-molecule protein kinase inhibitors.

Authors:  Ratika Krishnamurty; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

10.  Affinity-based probes based on type II kinase inhibitors.

Authors:  Pratistha Ranjitkar; B Gayani K Perera; Danielle L Swaney; Daniel L Swaney; Sanjay B Hari; Eric T Larson; Ratika Krishnamurty; Ethan A Merritt; Judit Villén; Dustin J Maly
Journal:  J Am Chem Soc       Date:  2012-11-06       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.